{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:45:43Z","timestamp":1793965543888,"version":"4.8.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.molmed.2024.02.009","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T13:07:54Z","timestamp":1710767274000},"page":"392-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Established and emerging treatments for eating disorders"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9824-4792","authenticated-orcid":false,"given":"Callum","family":"Bryson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daire","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2024.02.009_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-5-TR)","first-page":"372","article-title":"Feeding and eating disorders","author":"American Psychiatric Association","year":"2022"},{"key":"10.1016\/j.molmed.2024.02.009_bb0010","first-page":"889","article-title":"Eating disorders","volume":"395","author":"Treasure","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/15622975.2023.2179663","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders","volume":"24","author":"Himmerich","year":"2023","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1192\/bjp.2019.113","article-title":"Anorexia nervosa: 30-year outcome","volume":"216","author":"Dobrescu","year":"2020","journal-title":"British J. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/YCO.0000000000000360","article-title":"Evidence-based clinical guidelines for eating disorders","volume":"30","author":"Hilbert","year":"2017","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0030","article-title":"Family therapy approaches for anorexia nervosa","volume":"5","author":"Fisher","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.molmed.2024.02.009_bb0035","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/01.chi.0000161647.82775.0a","article-title":"A comparison of short- and long-term family therapy for adolescent anorexia nervosa","volume":"44","author":"Lock","year":"2005","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0040","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/1469-7610.00660","article-title":"Family therapy for adolescent anorexia nervosa: the results of a controlled comparison of two family interventions","volume":"41","author":"Eisler","year":"2000","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0045","article-title":"Who responds to an adaptive intervention for adolescents with anorexia nervosa being treated with family-based treatment? Outcomes from a randomized clinical trial","author":"Lock","year":"2023","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0050","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/eat.23611","article-title":"Feasibility of conducting a randomized controlled trial comparing family-based treatment via videoconferencing and online guided self-help family-based treatment for adolescent anorexia nervosa","volume":"54","author":"Lock","year":"2021","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.molmed.2024.02.009_bb0055","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/eat.23720","article-title":"Is guided self-help family-based treatment for parents of adolescents with anorexia nervosa on treatment waitlists feasible? A pilot trial","volume":"55","author":"Wade","year":"2022","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.molmed.2024.02.009_bb0060","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1017\/S0033291717002604","article-title":"Advances in the treatment of anorexia nervosa: a review of established and emerging interventions","volume":"48","author":"Brockmeyer","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.molmed.2024.02.009_bb0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S2215-0366(20)30566-6","article-title":"Comparative efficacy and acceptability of psychological interventions for the treatment of adult outpatients with anorexia nervosa: a systematic review and network meta-analysis","volume":"8","author":"Solmi","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104857","article-title":"Treatment of eating disorders: a systematic meta-review of meta-analyses and network meta-analyses","volume":"142","author":"Monteleone","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.molmed.2024.02.009_bb0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/13284207.2022.2075257","article-title":"A systematic review and meta-analysis of a 10-session cognitive behavioural therapy for non-underweight eating disorders","volume":"26","author":"Keegan","year":"2022","journal-title":"Clin. Psychol."},{"key":"10.1016\/j.molmed.2024.02.009_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/erv.3019","article-title":"Effectiveness of enhanced cognitive behaviour therapy for patients aged 14 to 25: a promising treatment for anorexia nervosa in transition-age youth","author":"Dalle Grave","year":"2023","journal-title":"Eur. Eat. Disord. Rev."},{"key":"10.1016\/j.molmed.2024.02.009_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/erv.2996","article-title":"The Maudsley model of anorexia nervosa treatment for adolescents and emerging adults: a multi-centre cohort study","author":"Wittek","year":"2023","journal-title":"Eur. Eat. Disord. Rev."},{"key":"10.1016\/j.molmed.2024.02.009_bb0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s40337-023-00886-w","article-title":"Psychotherapies for eating disorders: findings from a rapid review","volume":"11","author":"Russell","year":"2023","journal-title":"J. Eat. Disord."},{"key":"10.1016\/j.molmed.2024.02.009_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brat.2016.07.002","article-title":"Predictors and moderators of response to enhanced cognitive behaviour therapy and interpersonal psychotherapy for the treatment of eating disorders","volume":"84","author":"Cooper","year":"2016","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.molmed.2024.02.009_bb0100","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eat.22411","article-title":"Predictors of treatment outcome in individuals with eating disorders: a systematic review and meta-analysis","volume":"48","author":"Vall","year":"2015","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.molmed.2024.02.009_bb0105","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.mayocp.2019.02.030","article-title":"Rates of help-seeking in US adults with lifetime DSM-5 eating disorders: prevalence across diagnoses and differences by sex and ethnicity\/race","volume":"94","author":"Coffino","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.molmed.2024.02.009_bb0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clinthera.2020.11.006","article-title":"Current therapeutic approaches to anorexia nervosa: state of the art","volume":"43","author":"Muratore","year":"2021","journal-title":"Clin. Ther."},{"key":"10.1016\/j.molmed.2024.02.009_bb0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.9740\/mhc.2018.05.127","article-title":"Role of antidepressants in the treatment of adults with anorexia nervosa","volume":"8","author":"Marvanova","year":"2018","journal-title":"Ment. Health Clin."},{"key":"10.1016\/j.molmed.2024.02.009_bb0120","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1007\/BF03325129","article-title":"A 1-year follow-up of a multi-center treatment trial of adults with anorexia nervosa","volume":"16","author":"Yu","year":"2011","journal-title":"Eat. Weight Disord."},{"key":"10.1016\/j.molmed.2024.02.009_bb0125","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1001\/jama.295.22.2605","article-title":"Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial","volume":"295","author":"Walsh","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.molmed.2024.02.009_bb0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinthera.2020.10.006","article-title":"Psychotherapy and medications for eating disorders: better together?","volume":"43","author":"Reas","year":"2021","journal-title":"Clin. Ther."},{"key":"10.1016\/j.molmed.2024.02.009_bb0135","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1097\/MJT.0000000000000613","article-title":"An adolescent male with anorexia nervosa favorably responded to mirtazapine","volume":"25","author":"Naguy","year":"2018","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.molmed.2024.02.009_bb0140","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/eat.20793","article-title":"Use of mirtazapine in an adult with refractory anorexia nervosa and comorbid depression: a case report","volume":"44","author":"Safer","year":"2011","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.molmed.2024.02.009_bb0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1176\/appi.ajp.23180001","article-title":"The American Psychiatric Association practice guideline for the treatment of patients with eating disorders","volume":"180","author":"Crone","year":"2023","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1992.01820020059008","article-title":"Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo controlled, double-blind trial","volume":"49","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0155","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/104454603322572660","article-title":"An open trial of fluoxetine for adolescents with bulimia nervosa","volume":"13","author":"Kotler","year":"2003","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.molmed.2024.02.009_bb0160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1176\/appi.ajp.159.1.96","article-title":"A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment","volume":"159","author":"Romano","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0736-4679(01)00474-7","article-title":"Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department","volume":"22","author":"Pesola","year":"2002","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.molmed.2024.02.009_bb0170","first-page":"262","article-title":"Treatment of bulimia with bupropion: a multicenter controlled trial","volume":"49","author":"Horne","year":"1988","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2498","article-title":"Effectiveness of olanzapine in the treatment of anorexia nervosa: a systematic review and meta-analysis","volume":"12","author":"Han","year":"2022","journal-title":"Brain Behav."},{"key":"10.1016\/j.molmed.2024.02.009_bb0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.euroneuro.2021.08.001","article-title":"Lisdexamfetamine and binge-eating disorder: a systematic review and meta-analysis of the preclinical and clinical data with a focus on mechanism of drug action in treating the disorder","volume":"53","author":"Schneider","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.molmed.2024.02.009_bb0185","first-page":"33","article-title":"Binge-eating disorder","volume":"42","author":"Hilbert","year":"2018","journal-title":"Psychiatric Clin."},{"key":"10.1016\/j.molmed.2024.02.009_bb0190","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2147\/NDT.S109637","article-title":"Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials","volume":"12","author":"Fornaro","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.molmed.2024.02.009_bb0195","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamapsychiatry.2017.1889","article-title":"Efficacy of lisdexamfetamine in adults with moderate to severe binge-eating disorder","volume":"74","author":"Hudson","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11920-022-01340-5","article-title":"Psychopharmacologic management of eating disorders","volume":"24","author":"Muratore","year":"2022","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.molmed.2024.02.009_bb0205","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s40263-014-0166-2","article-title":"A systematic review of the safety of lisdexamfetamine dimesylate","volume":"28","author":"Coghill","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.molmed.2024.02.009_bb0210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamapsychiatry.2014.2162","article-title":"Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial","volume":"72","author":"McElroy","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0215","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.tem.2021.07.010","article-title":"Reframing anorexia nervosa as a metabo-psychiatric disorder","volume":"32","author":"Bulik","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2024.02.009_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/erv.3039","article-title":"Novel treatments for anorexia nervosa: insights from neuroplasticity research","author":"Keeler","year":"2023","journal-title":"Eur. Eat. Disord Rev."},{"key":"10.1016\/j.molmed.2024.02.009_bb0225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.wneu.2022.09.114","article-title":"Effectiveness of deep brain stimulation in treatment of anorexia nervosa and obesity: a systematic review","volume":"168","author":"Hsu","year":"2022","journal-title":"World Neurosurg."},{"key":"10.1016\/j.molmed.2024.02.009_bb0230","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41398-022-02102-w","article-title":"Efficacy and safety of deep brain stimulation for treatment-refractory anorexia nervosa: a systematic review and meta-analysis","volume":"12","author":"Karaszewska","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0235","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/2022.11.FOCUS22616","article-title":"Efficacy of deep brain stimulation for the treatment of anorexia nervosa: a systematic review and network meta-analysis of patient-level data","volume":"54","author":"Shaffer","year":"2023","journal-title":"Neurosurg. Focus."},{"key":"10.1016\/j.molmed.2024.02.009_bb0240","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-021531","article-title":"Randomised controlled feasibility trial of real versus sham repetitive transcranial magnetic stimulation treatment in adults with severe and enduring anorexia nervosa: the TIARA study","volume":"8","author":"Dalton","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.molmed.2024.02.009_bb0245","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/erv.2766","article-title":"Repetitive transcranial magnetic stimulation treatment in severe, enduring anorexia nervosa: an open longer-term follow-up","volume":"28","author":"Dalton","year":"2020","journal-title":"Eur. Eat. Disord. Rev."},{"key":"10.1016\/j.molmed.2024.02.009_bb0250","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/erv.2475","article-title":"A lack of clinical effect of high-frequency rTMS to dorsolateral prefrontal cortex on bulimic symptoms: a randomised, double-blind trial","volume":"24","author":"Gay","year":"2016","journal-title":"Eur. Eat. Disord. Rev."},{"key":"10.1016\/j.molmed.2024.02.009_bb0255","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000110061","article-title":"Repetitive transcranial magnetic stimulation in bulimia nervosa: preliminary results of a single-centre, randomised, double-blind, sham-controlled trial in female outpatients","volume":"77","author":"Walpoth","year":"2007","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.molmed.2024.02.009_bb0260","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/eat.22942","article-title":"Improving decision-making and cognitive impulse control in bulimia nervosa by rTMS: an ancillary randomized controlled study","volume":"51","author":"Guillaume","year":"2018","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.molmed.2024.02.009_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.717255","article-title":"Effects of transcranial direct current stimulation treatment for anorexia nervosa","volume":"12","author":"Baumann","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0270","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40337-022-00544-7","article-title":"Ameliorating cognitive control in patients with binge eating disorder by electrical brain stimulation: study protocol of the randomized controlled ACCElect pilot trial","volume":"10","author":"Giel","year":"2022","journal-title":"J. Eat. Disord."},{"key":"10.1016\/j.molmed.2024.02.009_bb0275","article-title":"A feasibility randomised sham-controlled trial of concurrent self-administered transcranial direct current stimulation (tDCS) and attention bias modification training in binge eating disorder","author":"Flynn","year":"2023","journal-title":"PsyArXiv"},{"key":"10.1016\/j.molmed.2024.02.009_bb0280","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.7898","article-title":"The use of virtual reality in patients with eating disorders: systematic review","volume":"20","author":"Clus","year":"2018","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.molmed.2024.02.009_bb0285","doi-asserted-by":"crossref","DOI":"10.2196\/16386","article-title":"Bringing virtual reality from clinical trials to clinical practice for the treatment of eating disorders: an example using virtual reality cue exposure therapy","volume":"22","author":"Brown","year":"2020","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.molmed.2024.02.009_bb0290","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/cpp.2622","article-title":"Virtual reality in the treatment of eating disorders","volume":"28","author":"Riva","year":"2021","journal-title":"Clin. Psychol. Psychother."},{"key":"10.1016\/j.molmed.2024.02.009_bb0295","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.3390\/jcm11174956","article-title":"Various types of virtual reality-based therapy for eating disorders: a systematic review","volume":"11","author":"Ci\u0105\u017cy\u0144ska","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.molmed.2024.02.009_bb0300","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev-clinpsy-081219-115923","article-title":"Virtual reality therapy in mental health","volume":"17","author":"Emmelkamp","year":"2021","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.molmed.2024.02.009_bb0305","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/jcm10040682","article-title":"AN-VR-BE. A randomized controlled trial for reducing fear of gaining weight and other eating disorder symptoms in anorexia nervosa through virtual reality-based body exposure","volume":"10","author":"Porras-Garcia","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.molmed.2024.02.009_bb0310","doi-asserted-by":"crossref","unstructured":"Varallo, G. et al. Virtual reality\u2013enhanced cognitive\u2013behavioral therapy for obese patients with bulimia nervosa: a pilot study with one-year follow-up. PsyArXiv. Published online June 8, 2020. https:\/\/doi.org\/10.31234\/osf.io\/6kfvr","DOI":"10.31234\/osf.io\/6kfvr"},{"key":"10.1016\/j.molmed.2024.02.009_bb0315","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.psychres.2013.02.023","article-title":"Effectiveness of cognitive behavioral therapy supported by virtual reality in the treatment of body image in eating disorders: one year follow-up","volume":"209","author":"Marco","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.molmed.2024.02.009_bb0320","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/erv.2538","article-title":"A randomised controlled comparison of second-level treatment approaches for treatment-resistant adults with bulimia nervosa and binge eating disorder: assessing the benefits of virtual reality cue exposure therapy","volume":"25","author":"Ferrer-Garc\u00eda","year":"2017","journal-title":"Eur. Eat. Disord. Rev."},{"key":"10.1016\/j.molmed.2024.02.009_bb0325","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/cyber.2017.0675","article-title":"A randomized trial of virtual reality-based cue exposure second-level therapy and cognitive behavior second-level therapy for bulimia nervosa and binge-eating disorder: outcome at six-month follow-up","volume":"22","author":"Ferrer-Garcia","year":"2019","journal-title":"Cyberpsychol. Behav."},{"key":"10.1016\/j.molmed.2024.02.009_bb0330","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1109\/TITB.2002.802372","article-title":"Virtual-reality-based multidimensional therapy for the treatment of body image disturbances in binge eating disorders: a preliminary controlled study","volume":"6","author":"Riva","year":"2002","journal-title":"IEEE Trans. Inf. Technol. Biomed."},{"key":"10.1016\/j.molmed.2024.02.009_bb0335","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/109493103322011533","article-title":"Six-month follow-up of in-patient experiential cognitive therapy for binge eating disorders","volume":"6","author":"Riva","year":"2003","journal-title":"Cyberpsychol. Behav."},{"key":"10.1016\/j.molmed.2024.02.009_bb0340","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.2441","article-title":"Virtual reality for enhancing the cognitive behavioral treatment of obesity with binge eating disorder: randomized controlled study with one-year follow-up","volume":"15","author":"Cesa","year":"2013","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.molmed.2024.02.009_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2023.05.008","article-title":"Psychedelics in the treatment of eating disorders: rationale and potential mechanisms","volume":"75","author":"Calder","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.molmed.2024.02.009_bb0350","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s44192-022-00012-3","article-title":"Ketamine treatment for depression: a review","volume":"2","author":"Yavi","year":"2022","journal-title":"Discov. Ment. Health"},{"key":"10.1016\/j.molmed.2024.02.009_bb0355","doi-asserted-by":"crossref","first-page":"373","DOI":"10.26502\/fjwhd.2644-28840044","article-title":"Ketamine in a patient with comorbid anorexia and MDD","volume":"3","author":"Dechant","year":"2020","journal-title":"J. Womens Health Dev."},{"key":"10.1016\/j.molmed.2024.02.009_bb0360","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1007\/s40519-022-01455-x","article-title":"Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study","volume":"27","author":"Calabrese","year":"2022","journal-title":"Eat. Weight Disord."},{"key":"10.1016\/j.molmed.2024.02.009_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1181447","article-title":"Case report: intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa","volume":"14","author":"Keeler","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0370","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/qjmed\/91.7.493","article-title":"Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions","volume":"91","author":"Mills","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.molmed.2024.02.009_bb0375","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fpsyt.2021.764112","article-title":"Case report: unexpected remission from extreme and enduring bulimia nervosa with repeated ketamine assisted psychotherapy","volume":"12","author":"Ragnhildstveit","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0380","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40337-022-00588-9","article-title":"A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders","volume":"10","author":"Robison","year":"2022","journal-title":"J. Eat. Disord."},{"key":"10.1016\/j.molmed.2024.02.009_bb0385","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.3869","article-title":"A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment-resistant depression","volume":"9","author":"Schwartz","year":"2021","journal-title":"Clin. Case Reports"},{"key":"10.1016\/j.molmed.2024.02.009_bb0390","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3389\/fpsyt.2020.00763","article-title":"Remission from chronic anorexia nervosa with ketogenic diet and ketamine: case report","volume":"11","author":"Scolnick","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1141988","article-title":"Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses","volume":"14","author":"Wolfson","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0400","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/09540261.2020.1854194","article-title":"Ketamine for depression","volume":"33","author":"Jelen","year":"2021","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0405","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/s41591-023-02455-9","article-title":"Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study","volume":"29","author":"Peck","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2024.02.009_bb0410","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-14-0405","article-title":"Leptin at 20: an overview","volume":"223","author":"Friedman","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.molmed.2024.02.009_bb0415","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.yfrne.2003.10.001","article-title":"Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance","volume":"24","author":"Sahu","year":"2003","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.molmed.2024.02.009_bb0420","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fnins.2018.00271","article-title":"Hedonic eating and the \u201cdelicious circle\u201d: from lipid-derived mediators to brain dopamine and back","volume":"12","author":"Coccurello","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.molmed.2024.02.009_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113071","article-title":"Reward and psychopathological correlates of eating disorders: the explanatory role of leptin","volume":"290","author":"Cassioli","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.molmed.2024.02.009_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.733606","article-title":"Suggestive evidence for causal effect of leptin levels on risk for anorexia nervosa: results of a mendelian randomization study","volume":"12","author":"Peters","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.molmed.2024.02.009_bb0435","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3389\/fpsyg.2019.00769","article-title":"Clinical trials required to assess potential benefits and side effects of treatment of patients with anorexia nervosa with recombinant human leptin","volume":"10","author":"Hebebrand","year":"2019","journal-title":"Front. Psychol."},{"key":"10.1016\/j.molmed.2024.02.009_bb0440","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00787-021-01778-7","article-title":"Rapid amelioration of anorexia nervosa in a male adolescent during metreleptin treatment including recovery from hypogonadotropic hypogonadism","volume":"31","author":"Antel","year":"2021","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0445","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000527386","article-title":"Rapid emergence of appetite and hunger resulting in weight gain and improvement of eating disorder symptomatology during and after short-term off-label metreleptin treatment of a patient with anorexia nervosa","volume":"16","author":"Gradl-Dietsch","year":"2022","journal-title":"Obes. Facts"},{"key":"10.1016\/j.molmed.2024.02.009_bb0450","article-title":"Case report: clinical improvements observed in first off-label metreleptin treatment of a patient with atypical anorexia nervosa","author":"Hebebrand","year":"2023","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0455","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41398-020-00977-1","article-title":"Short-term metreleptin treatment of patients with anorexia nervosa: rapid on-set of beneficial cognitive, emotional, and behavioral effects","volume":"10","author":"Milos","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.molmed.2024.02.009_bb0460","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1192\/bjp.2023.160","article-title":"Not niche: eating disorders as an example in the dangers of overspecialisation","volume":"224","author":"Haynos","year":"2023","journal-title":"Br. J. Psychiatry"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424000340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424000340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T16:04:19Z","timestamp":1727885059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491424000340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1471491424000340"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2024.02.009","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Established and emerging treatments for eating disorders","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2024.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}